SGS Life Science Services is pleased to be hosting a live seminar at the London Imperial College on the successful early phase development of biotech compounds.

As the biotech industry in Europe matures and more biotech drug candidates reach clinical development, expertise for clinical project planning and management is increasingly in demand. The aim of this seminar is to discuss strategies for efficiently moving (bio) pharmaceuticals forward through the crucial early phases of the clinical trial process. Through five lectures, SGS will cover key topics including: regulatory guidance, use of new bioanalytical and biomarker technology in clinical research and innovative, combined designs in early phase clinical trials and overcoming the challenges of early patient trials.

Scientific Program:

  • Regulatory Guidance on the EU Biotech Environment; Arash Ghalamkarpour, MD, PhD, Regulatory Affairs Associate
  • SGS Use of New Bio-Analytical and Biomarker Technology in Clinical Research; Alain Coquette, PhD, Manager of the Division of Applied Biology
  • SGS Saving Drug Development Time, Thanks to Accurate Preclinical Method Development and Validation; Cédric Volanti, PhD, Bioetch R&D / QC testing manager
  • SGS Innovative Combined Designs in Early Phase Clinical Trials: From First In-Human Trial to Proof of Concept; Omer Van Schoor, PhD, Director of the Clinical Pharmacology Unit of SGS
  • SGS Early Phase Clinical Trials in Patients: Bridging Studies from Healthy Volunteers to Patients Trials; Dr. Robert Lins, Managing Director, MD, SGS

For more information about this event, or to register, please visit the Biotech Drug Development Seminar page.

For more information, you may contact:

Florent Hediard
173 rue de la Croix Nivert
75015 Paris- France
t: +33 (0) 1 53 78 18 74
f: +33 (0)1 45 54 28 64

About SGS

The SGS Group is the global leader and innovator in inspection, verification, testing and certification services. Founded in 1878, SGS is recognized as the global benchmark in quality and integrity. With 59,000 employees, SGS operates a network of over 1,000 offices and laboratories around the world.